论文部分内容阅读
Despite optimal therapeutic regimen with available antiepileptic drugs (AEDs),approximately a third of epilepsy patients remain drug refractory.Region-specific overexpression of multidrug efflux transporters at the blood–brain barrier,such as P-glycoprotein (P-gp),might contribute to multidrug resistance (MDR) by reducing target concentrations of AEDs.